Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentation.

Cell Rep Med · 2025 · PMC12765948 · PMID 41406943

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Other components of the antigen presentation machinery—PSMB9, TAPBP, TAP2, B2M, HLA-A, and HLA-C—also showed a trend of increased protein levels, though to a lesser extent.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.